Valuation — not yet established
No valuation for Regulus Therapeutics is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($100.0M) and the funding record below are the closest available signals.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
- ·Post-money valuations for all 6 rounds
- ·Watchlist + deal alerts for Regulus Therapeutics
Create free account
No card required
Funding history
6 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Mar 2024 | PIPE | $100.0M | ▮ | ▮ |
| Nov 2021 | Early Stage VC | $34.6M | ▮ | ▮ |
| Dec 2020 | Early Stage VC | $19.4M | ▮ | ▮ |
| May 2019 | Early Stage VC | $16.7M | ▮ | ▮ |
| Oct 2012 | Early Stage VC | $25.0M | ▮ | ▮ |
| Aug 2012 | Early Stage VC | $5.0M | ▮ | ▮ |
How Regulus Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Regulus Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- How much has Regulus Therapeutics raised?
- Regulus Therapeutics has raised $100.0M in total funding across 6 recorded rounds.
- When did Regulus Therapeutics last raise?
- Regulus Therapeutics last raised in Mar 2024 (PIPE), raising $100.0M.